首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study

【24h】

Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study

机译：移植后环磷酰胺降低强度后HLA-单倍型外周血干细胞移植的多中心II期前瞻性研究：JSCT Haplo13研究的首次分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2015年第1期|共2页
作者
Sugita Junichi; Kawashima Naomi; Fujisaki Tomoaki; Kakihana Kazuhiko; Uchida Naoyuki; Maeda Yoshinobu; Ota Shuichi; Matsuo Keitaro; Miyamoto Toshihiro; Nagafuji Koji; Eto Tetsuya; Akashi Koichi; Taniguchi Shuichi; Harada Mine; Teshima Takanori;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study [J] . Sugita Junichi, Kawashima Naomi, Fujisaki Tomoaki, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：移植后环磷酰胺降低强度后HLA-单倍型外周血干细胞移植的多中心II期前瞻性研究：JSCT Haplo13研究的首次分析
2. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning [J] . Sugita Junichi, Kawashima Naomi, Fujisaki Tomoaki, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第9期

机译：HLA-Haploidentical外周血干细胞移植在含含套血管的降低强度调节后移植后环磷酰胺
3. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04) [J] . Murayama Tohru, Fukuda Takahiro, Okumura Hirokazu, International journal of hematology . 2016,第6期

机译：前期大剂量化疗加利妥昔单抗+自体外周血干细胞移植治疗未治疗的高中，高风险弥漫性大B细胞淋巴瘤的疗效：一项多中心前瞻性II期研究（JSCT-NHL04）
4. SUPERIOR SURVIVAL IN PRIMARY SYSTEMIC AMYLOIDOSIS PATIENTS UNDERGOING PERIPHERAL BLOOD STEM CELL TRANSPLANT : A CASE CONTROL STUDY [C] . A. Dispenzieri, R.A. Kyle, M.Q. Lacy, International Symposium on Amyloidosis . 2005

机译：初级全身淀粉样蛋白患者的优越存活患者接受外周血干细胞移植：案例对照研究
5. Adaptation to breast cancer following an autologous peripheral blood stem cell transplant: A prospective study. [D] . Dales, Christina Michelle. 2001

机译：自体外周血干细胞移植后对乳腺癌的适应性：一项前瞻性研究。
6. A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies [O] . Melhem M. Solh, Gabriel Hinojosa, Justin Laporte, 2021

机译：基于Melphalan的蛋白酶的蛋白酶减少强度调节的II期试验用于血液学恶性肿瘤患者患者患有后翻译植物环磷酰胺
7. Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study [O] . Sugita Junichi, Kawashima Naomi, Fujisaki Tomoaki, 2015

机译：移植后环磷酰胺降低强度调节后HLA-单倍型外周血干细胞移植的多中心II期前瞻性研究：JSCT Haplo13研究的首次分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号